Key result
Both phenylephrine and ephedrine can be used safely to treat hypotension during cesarean delivery, and ephedrine should not be discarded based on current evidence.
Why the study?
Should ephedrine be discarded in favor of phenylephrine for treating spinal anesthesia-induced hypotension during cesarean delivery?
Should ephedrine be discarded in favor of phenylephrine for treating spinal anesthesia-induced hypotension during cesarean delivery?
Answers are grounded in this paper and cite their sources.
This editorial advocates against the complete discontinuation of ephedrine, suggesting a balanced approach using both phenylephrine and ephedrine for managing spinal hypotension during cesarean delivery.
We read with interest the articles by Ngan Kee et al. 1and Dyer et al. ,2as well as the editorial by Smiley,3all of which concern comparisons of phenylephrine and ephedrine for the treatment of hypotension associated with spinal anesthesia for cesarean delivery (CD). It is reassuring to know that phenylephrine can be used safely in this setting, something that I (D.R.G.) have advocated to residents and colleagues for more than 10 yr. However, it is important to remember that ephedrine too has been used safely for decades to treat hypotension after induction of spinal anesthesia for CD. Therefore, it is crucial that the results of these recent studies are put into perspective and do not lead to an imposed or voluntary discontinuation of ephedrine use during CD. The reasons for this are as follows:We would not want to see ephedrine discarded based on the evidence reported to date. Instead, we advocate a common sense approach to the treatment of spinal hypotension during CD. For example, phenylephrine could be used as a first-line treatment, with ephedrine being used either as a second-line treatment or in combination with phenylephrine. Maternal heart rate can be used as a guide to therapy. In addition, it may be prudent to use phenylephrine as the first-line agent in nonelective CD because small differences in fetal pH may have greater effect on clinical neonatal outcome in cases of intrauterine fetal stress. To date, however, studies have failed to show a significant difference in pH or clinical neonatal outcome in this setting, regardless of the vasopressor used.10Ultimately, more research is necessary to look beyond initial umbilical cord blood gas measurements in the delivery room and instead at more long-term neonatal outcomes. This is especially true for cases of CD in which there is suspected fetal compromise. Until such data are available, do not “throw away” the ephedrine syringe, but rather use a common sense approach based on sound clinical judgment when treating maternal hypotension in this setting.*Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, and University of California, San Diego, San Diego, California. david.gambling@sharp.com
No takes yet. Share an insight, caveat, or question.
Gambling et al. (2010) conducted a letter in Hypotension associated with spinal anesthesia for cesarean delivery. Ephedrine and Phenylephrine was evaluated. Both phenylephrine and ephedrine can be used safely to treat hypotension during cesarean delivery, and ephedrine should not be discarded based on current evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: